421 related articles for article (PubMed ID: 27613807)
1. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials.
Orbai AM; de Wit M; Mease P; Shea JA; Gossec L; Leung YY; Tillett W; Elmamoun M; Callis Duffin K; Campbell W; Christensen R; Coates L; Dures E; Eder L; FitzGerald O; Gladman D; Goel N; Grieb SD; Hewlett S; Hoejgaard P; Kalyoncu U; Lindsay C; McHugh N; Shea B; Steinkoenig I; Strand V; Ogdie A
Ann Rheum Dis; 2017 Apr; 76(4):673-680. PubMed ID: 27613807
[TBL] [Abstract][Full Text] [Related]
2. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
[TBL] [Abstract][Full Text] [Related]
3. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.
Coates LC; FitzGerald O; Merola JF; Smolen J; van Mens LJJ; Bertheussen H; Boehncke WH; Callis Duffin K; Campbell W; de Wit M; Gladman D; Gottlieb A; James J; Kavanaugh A; Kristensen LE; Kvien TK; Luger T; McHugh N; Mease P; Nash P; Ogdie A; Rosen CF; Strand V; Tillett W; Veale DJ; Helliwell PS
Arthritis Rheumatol; 2018 Mar; 70(3):345-355. PubMed ID: 29193765
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative.
Højgaard P; Klokker L; Orbai AM; Holmsted K; Bartels EM; Leung YY; Goel N; de Wit M; Gladman DD; Mease P; Dreyer L; Kristensen LE; FitzGerald O; Tillett W; Gossec L; Helliwell P; Strand V; Ogdie A; Terwee CB; Christensen R
Semin Arthritis Rheum; 2018 Apr; 47(5):654-665. PubMed ID: 29037523
[TBL] [Abstract][Full Text] [Related]
6. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.
Perez-Chada LM; Gottlieb AB; Cohen J; Mease P; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
J Am Acad Dermatol; 2020 Jan; 82(1):54-61. PubMed ID: 31163240
[TBL] [Abstract][Full Text] [Related]
7. Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study.
Conaghan PG; Alten R; Deodhar A; Sullivan E; Blackburn S; Tian H; Gandhi K; Jugl SM; Strand V
RMD Open; 2020 Jun; 6(2):. PubMed ID: 32611650
[TBL] [Abstract][Full Text] [Related]
8. PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
Orbai AM; Holland R; Leung YY; Tillett W; Goel N; Christensen R; McHugh N; Gossec L; de Wit M; Højgaard P; Coates LC; Mease PJ; Birt J; Fallon L; FitzGerald O; Ogdie A; Shea B; Strand V; Duffin KC; Tugwell P; Beaton D; Gladman DD
J Rheumatol; 2019 Aug; 46(8):990-995. PubMed ID: 30554154
[TBL] [Abstract][Full Text] [Related]
9. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.
Holland R; Tillett W; Ogdie A; Leung YY; Gladman DD; Callis Duffin K; Coates LC; Mease PJ; Eder L; Strand V; Elmamoun M; Højgaard P; Chau J; de Wit M; Goel N; Lindsay CA; FitzGerald O; Shea B; Beaton D; Orbai AM
J Rheumatol Suppl; 2018 Jun; 94():17-25. PubMed ID: 29858348
[TBL] [Abstract][Full Text] [Related]
10. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.
Gossec L; de Wit M; Kiltz U; Braun J; Kalyoncu U; Scrivo R; Maccarone M; Carton L; Otsa K; Sooäär I; Heiberg T; Bertheussen H; Cañete JD; Sánchez Lombarte A; Balanescu A; Dinte A; de Vlam K; Smolen JS; Stamm T; Niedermayer D; Békés G; Veale D; Helliwell P; Parkinson A; Luger T; Kvien TK;
Ann Rheum Dis; 2014 Jun; 73(6):1012-9. PubMed ID: 24790067
[TBL] [Abstract][Full Text] [Related]
11. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
[TBL] [Abstract][Full Text] [Related]
12. Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.
Orbai AM; McInnes IB; Coates LC; Husni ME; Gladman DD; Gossec L; Pricop L; Chambenoit O; Meng X; Mease PJ
J Rheumatol; 2020 Jun; 47(6):854-864. PubMed ID: 31615919
[TBL] [Abstract][Full Text] [Related]
13. Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.
Orbai AM; Mease PJ; de Wit M; Kalyoncu U; Campbell W; Tillett W; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; Gossec L; Lindsay CA; Steinkoenig I; Helliwell PS; McHugh NJ; Strand V; Ogdie A
J Rheumatol; 2016 May; 43(5):965-9. PubMed ID: 27134271
[TBL] [Abstract][Full Text] [Related]
14. Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire.
Coates LC; Orbai AM; Azevedo VF; Cappelleri JC; Steinberg K; Lippe R; Lim I; Eder L; Richette P; Weng MY; Queiro Silva R; Fallon L
Health Qual Life Outcomes; 2020 Jun; 18(1):173. PubMed ID: 32513190
[TBL] [Abstract][Full Text] [Related]
15. Consensus on a core set of domains for psoriatic arthritis.
Gladman DD; Mease PJ; Strand V; Healy P; Helliwell PS; Fitzgerald O; Gottlieb AB; Krueger GG; Nash P; Ritchlin CT; Taylor W; Adebajo A; Braun J; Cauli A; Carneiro S; Choy E; Dijkmans B; Espinoza L; van der Heijde D; Husni E; Lubrano E; McGonagle D; Qureshi A; Soriano ER; Zochling J
J Rheumatol; 2007 May; 34(5):1167-70. PubMed ID: 17477480
[TBL] [Abstract][Full Text] [Related]
16. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.
Ogdie A; de Wit M; Callis Duffin K; Campbell W; Chau J; Coates LC; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; James J; Kalyoncu U; Latella J; Lindsay C; Mease PJ; O'Sullivan D; Steinkoenig I; Strand V; Tillett W; Orbai AM
J Rheumatol; 2017 May; 44(5):697-700. PubMed ID: 28461531
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes in psoriatic arthritis: A systematic literature review.
Palominos PE; Gaujoux-Viala C; Fautrel B; Dougados M; Gossec L
Arthritis Care Res (Hoboken); 2012 Mar; 64(3):397-406. PubMed ID: 22147535
[TBL] [Abstract][Full Text] [Related]
18. Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report.
Duarte-García A; Leung YY; Coates LC; Beaton D; Christensen R; Craig ET; de Wit M; Eder L; Fallon L; FitzGerald O; Gladman DD; Goel N; Holland R; Lindsay C; Maxwell L; Mease P; Orbai AM; Shea B; Strand V; Veale DJ; Tillett W; Ogdie A
J Rheumatol; 2019 Aug; 46(8):996-1005. PubMed ID: 30770518
[TBL] [Abstract][Full Text] [Related]
19. Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set.
Kalyoncu U; Ogdie A; Campbell W; Bingham CO; de Wit M; Gladman DD; Mease P; Steinkoenig I; Strand V; Riese VG; Orbai AM
RMD Open; 2016; 2(1):e000217. PubMed ID: 26966554
[TBL] [Abstract][Full Text] [Related]
20. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.
Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW
JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
